Ming Wei

2.3k total citations
110 papers, 1.7k citations indexed

About

Ming Wei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ming Wei has authored 110 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 14 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Ming Wei's work include RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (10 papers) and Infectious Diseases and Mycology (6 papers). Ming Wei is often cited by papers focused on RNA modifications and cancer (11 papers), Cancer-related molecular mechanisms research (10 papers) and Infectious Diseases and Mycology (6 papers). Ming Wei collaborates with scholars based in China, United States and Taiwan. Ming Wei's co-authors include Xue‐yi You, Weihong Wen, Angang Yang, Zhangyan Guo, Zifan Lu, Gangcai Zhu, Li She, Shengjia Shi, Lijuan Wang and Guodong Wang and has published in prestigious journals such as PLoS ONE, Oncogene and The FASEB Journal.

In The Last Decade

Ming Wei

101 papers receiving 1.7k citations

Peers

Ming Wei
Comparison fields: 5 of 153
  • Molecular Biology 682
  • Oncology 309
  • Cancer Research 283
  • Physiology 229
  • Immunology 198
Replace Zhiwen Luo with:
Zhiwen Luo China
Sabina Pucci Italy
Haiying Chen China
Zhenlong Chen China
Guannan Wang China
Zhi Yang China
Dongjun Lee South Korea
Pengfei Li China
Kyung Ho Lee South Korea
Yuwei Li China
Zhiwen Luo China View profile →
Citations per field, relative to Ming Wei
Ming Wei · 1×
Citations per year, relative to Ming Wei
Ming Wei · 1×

Countries citing papers authored by Ming Wei

Since Specialization
Citations

This map shows the geographic impact of Ming Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Wei more than expected).

Fields of papers citing papers by Ming Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Wei. The network helps show where Ming Wei may publish in the future.

Co-authorship network of co-authors of Ming Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Wei. A scholar is included among the top collaborators of Ming Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Wei. Ming Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 0
3 0
4 1
5 1
6 0
7 2
8 1
9 9
10 5
11 2
12 13
13 10
14 3
15 42
16 0
17 31
18 1
19
Clinical study of rheumatoid arthritis with midnight-noon ebb-flow acupoint selection.
1
20
Relationship between IL-13 Exon 4 Gene Polymorphisms A2 044G and the Patients with Asthma
3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026